| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000019332 |
| Receipt No. | R000022159 |
| Official scientific title of the study | Volume expanding effect and peripheral perfusion of 130 HES in the patients during perioperative period |
| Date of disclosure of the study information | 2015/10/13 |
| Last modified on | 2016/06/27 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Volume expanding effect and peripheral perfusion of 130 HES in the patients during perioperative period | |
| Title of the study (Brief title) | Efficacy of 130 HES in the patients during perioperative period | |
| Region |
|
|
| Condition | ||
| Condition | Perioperative patients | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We will compare the effect of 130 HES in volume expansion, hemodynamic parameters and peripheral perfusion with that of 70 HES and bicarbonated Ringer solution. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Increase of circulation blood volume at 10 minutes after the administration of 130 HES, 70HES or bicarbonated Ringer solution. |
| Key secondary outcomes | Changes of blood pressure, heart rate, peripheral perfusion index and hemoglobin at 10 minutes after the administration of 130 HES, 70HES or bicarbonated Ringer solution. |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intravenous administration of 500 ml of 130 HES in 10 minutes | |
| Interventions/Control_2 | Intravenous administration of 500 ml of 70 HES in 10 minutes | |
| Interventions/Control_3 | Intravenous administration of 500 ml of bicarbonated Ringer solution in 10 minutes | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with 1-2 of ASA physical status in elective surgery. | |||
| Key exclusion criteria | Patients with cardiovascular disease, hemorrhage and/or dehydration. | |||
| Target sample size | 120 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroaki Toyama |
| Organization | Tohoku University hospital |
| Division name | Department of Anesthesiology |
| Address | 1-1 Seiryomachi, Aoba-ku, Sendai, Japan |
| TEL | 022-717-7321 |
| h-toyama@umin.ac.jp | |
| Public contact | |
| Name of contact person | Hiroaki Toyama |
| Organization | Tohoku University Hospital |
| Division name | Department of Anesthesiology |
| Address | 1-1 Seiryomachi, Aoba-ku, Sendai, Japan |
| TEL | 022-717-7321 |
| Homepage URL | |
| h-toyama@umin.ac.jp | |
| Sponsor | |
| Institute | Department of Anesthesiology, Tohoku University Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Department of Anesthesiology, Tohoku University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | None |
| Name of secondary funder(s) | None |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東北大学病院(宮城県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022159 |